Skip to main content
. Author manuscript; available in PMC: 2023 Apr 15.
Published before final editing as: Eur J Cancer. 2021 Oct 15;158:99–110. doi: 10.1016/j.ejca.2021.09.010

Figure 3:

Figure 3:

Incidence rates of venous thromboembolism events (deep vein thrombosis, pulmonary embolism, deep vein thrombosis/pulmonary embolism) before and after initiation of immune checkpoint inhibitors- excluding those who died within 1 year of starting ICI (n=2077)